Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8728454 | Gastrointestinal Endoscopy | 2018 | 23 Pages |
Abstract
RFA of the gastric remnant pouch in patients with weight regain after RYGB resulted in significant reductions in excess body weight with an acceptable safety profile. Continued weight loss was observed after each RFA treatment. Further clinical trials in well-selected populations are warranted to determine the optimal number and frequency of RFA treatments and to assess durability of weight loss. (Clinical trial registration number: NCT01910688.)
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Julian A. MD, MS, Sri MD, Nicholas J. MD, MPH, Zengri PhD, Richard I. MD,